Mr Rajeev Nannapaneni, Chief Operating Officer of Natco Pharma Ltd, has been elevated to the position of Vice-Chairman and Chief Executive Officer of the company.
Mr Rajiv, who joined the Hyderabad-based company’s board in 2005, would be in-charge of all day-to-day operations and oversee all functional areas, Nacto said in a release issued here on Thursday.
Mr Rajeev was instrumental in Natco obtaining the first-ever compulsory licence in India for the generic version of Bayer’s Nexavar, a drug used in the treatment of kidney and liver cancers, it added.